0 likes | 7 Vues
Healthark Insights shares key trends shaping the pharma industry in 2025u2014from digital transformation to innovation-driven growth strategies.
E N D
Pharma Industry Outlook 2025: Trends & Strategies As we move through 2025, the pharmaceutical industry is undergoing a transformation fueled by innovation, data, and a redefined approach to patient care. Here are five strategic shifts reshaping the landscape
Evolving Portfolios Through Scientific Breakthroughs Embracing novel modalities and new MOAs (e.g., Precigen’s non-surgical treatment for RRP) Expanding focus beyond oncology/immunology into Alzheimer’s, weight management, Lp(a)-targeting assets Streamlining pipelines—like Roche narrowing disease areas to drive focus Driving launch excellence with continuous innovation (GSK: 12 launches expected in 2025)
Accelerating R&D with Data, AI & Patient-Centric Trials 85% of execs are investing in AI by 2025 Amgen cut enrollment time in half using ML Sanofi + OpenAI are slashing recruitment time from months to minutes Moderna and Sanofi achieved 80% diversity in trials with online platforms
Building Sustainable, Resilient Supply Chains Geopolitical and margin pressures are prompting investment in smart manufacturing Companies like Amgen and Roche are leading efficiency upgrades
Transforming Customer Engagement Omnichannel personalization via AI (Takeda, Pfizer) Ecosystem collaboration—Novo Nordisk + MIT + Harvard + Broad Institute targeting T2D
Enhancing Patient Engagement Across the Care Journey Digital platforms like PfizerForAll and LillyDirect are revolutionizing access to care and treatment